Cervical Cancer

CDC Urges Pre-Teen Vaccination With New Public Service Announcements
The Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respiratory Diseases announced that new public service announcements (PSAs) targeting the parents of pre-teens are now available to broadcast organizations.

CDC, FDA Release Statement Saying HPV Vaccine Gardasil Remains Safe, Effective
Officials from CDC and FDA on Tuesday released a statement that says a review of available information by the two agencies has found that Merck's human papillomavirus vaccine Gardasil "continues to be safe and effective" for protecting women and girls from a virus that causes cervical cancer, and that its "benefits continue to outweigh its risks,"

Cervical Cancer Prevention In U.S. Should Focus On Vaccinating Adolescent Girls And Revising Screening Policies
The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women

Nventa Announces Final Data From HspE7 Phase 1 Cervical Dysplasia Trial
Nventa Biopharmaceuticals Corporation (TSX: NVN) announced that it has completed analysis of immunological data from all four cohorts of its Phase 1 clinical trial for HspE7, its lead product candidate. HspE7 is a therapeutic treatment for patients with cervical intraepithelial neoplasia, or CIN, a precursor to cervical cancer. The primary cause of CIN is infection with certain human papillomavirus (HPV) types, of which HPV16 is the most common.

Novel Structure Proteins Could Play A Role In Apoptosis
Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.

Minister Harney Approves Introduction Of Cervical Cancer Vaccination Programme
The Minister for Health and Children, Mary Harney T.D., announced that she has asked the HSE to prepare and submit a plan for the introduction of a HPV vaccination programme for 12 year old girls to commence in September 2009.

Nebraska Women Benefit From Efforts To Close Gaps In Cancer Screening
A decade-long Nebraska study that showed disparities in breast and cervical cancer screenings could have spurred changes that raised the percentage of women screened in the state. "Disparities in screening between racial and ethnic groups, even in a homogeneous state such as Nebraska, are a problem and by digging into some of the differences we were able to have an impact on breast and cervical cancer screening," said lead study author Shingairai Feresu, Ph.D.

Novel Structure Proteins Could Play A Role In Apoptosis
Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.

Los Angeles Times Examines Some Parents', Doctors' Reservations About HPV Vaccine Gardasil
The Los Angeles Times on Monday examined the "serious reservations" some doctors and parents have about providing Merck's human papillomavirus vaccine Gardasil, which prevents transmission of strains of HPV that can cause cervical cancer, to young girls. According to data from Merck, about eight million girls and women in the U.S.

Merck, FDA Update Potential Adverse Reactions To HPV Vaccine Gardasil, Washington Times Reports
The Washington Times on Thursday reported that Merck and FDA last month added potential adverse reactions to Merck's human papillomavirus vaccine Gardasil to the package insert and information sheet given to patients.

Advanced Laparoscopic Techniques And The Use Of Harmonic(R) Technology In Gynecologic Surgery
Join surgeons, Dr. Roger Ferland and Dr. Lori Warren, for a free one-hour live webcast highlighting the use of minimally invasive techniques in gynecologic surgery. The doctors will focus on the patient benefits of two approaches, Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy.

HPV Vaccine Gardasil Under Investigation For Adverse Events, New York Post Reports
Lawyers for two girls who received Merck's human papillomavirus vaccine Gardasil last month filed the first two claims under the federal Vaccine Injury Compensation Program, the New York Post reports.

Science Fiction Becomes Reality As Deadly Bacteria Battles Cancer
In the United States alone, approximately three-and-a-half million women have abnormal Pap smear tests each year. More than a third of these women develop cervical dysplasia, also known as Cervical Intraepithelial Neoplasia (CIN), a condition caused by the sexually transmitted Human Papilloma Virus (HPV). Stages I & II are considered a precancerous abnormality, but not an actual cancer; stage III is a pre-invasive form of cervical cancer.

Global Vaccine Alliance Board Approves $3.5B Investment Strategy That Includes HPV Vaccine
The board of the Global Alliance for Vaccines and Immunisation (GAVI) -- a public-private partnership that invests in childhood vaccinations in developing countries -- endorsed a $3.5 billion vaccine investment

Science Fiction Becomes Reality As Deadly Bacteria Battles Cancer
In the United States alone, approximately three-and-a-half million women have abnormal Pap smear tests each year. More than a third of these women develop cervical dysplasia, also known as Cervical Intraepithelial Neoplasia (CIN), a condition caused by the sexually transmitted Human Papilloma Virus (HPV). Stages I & II are considered a precancerous abnormality, but not an actual cancer; stage III is a pre-invasive form of cervical cancer.

Audit Finds Reported Cervical Cancer Cases In Maryland Deliberately Altered In State Database
The number of reported cervical cancer cases in Maryland was deliberately overreported in a state database that records the number of cancer cases statewide, according to a recent audit conducted by the Department of Legislative Services, the

Novel Structure Proteins Could Play A Role In Apoptosis
Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.

Minister Harney Approves Introduction Of Cervical Cancer Vaccination Programme
The Minister for Health and Children, Mary Harney T.D., announced that she has asked the HSE to prepare and submit a plan for the introduction of a HPV vaccination programme for 12 year old girls to commence in September 2009.

GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009
GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its human papillomavirus vaccine Cervarix until late 2009, Reuters reports. GSK said it has decided to wait until results from a Phase III trial of the vaccine are available before seeking U.S. approval.

Los Angeles Times Examines Some Parents', Doctors' Reservations About HPV Vaccine Gardasil
The Los Angeles Times on Monday examined the "serious reservations" some doctors and parents have about providing Merck's human papillomavirus vaccine Gardasil, which prevents transmission of strains of HPV that can cause cervical cancer, to young girls. According to data from Merck, about eight million girls and women in the U.S.

CDC, FDA Release Statement Saying HPV Vaccine Gardasil Remains Safe, Effective
Officials from CDC and FDA on Tuesday released a statement that says a review of available information by the two agencies has found that Merck's human papillomavirus vaccine Gardasil "continues to be safe and effective" for protecting women and girls from a virus that causes cervical cancer, and that its "benefits continue to outweigh its risks,"

GlaxoSmithKline Responds To FDA On Cervarix® And Plans To Submit Final Study Data For Approval
GlaxoSmithKline provided the following update regarding its application to the U.S. Food and Drug Administration (FDA) for approval of Cervarix®, its vaccine to prevent cervical cancer. GSK has submitted its response to questions raised by the FDA in their Complete Response Letter, received in December, 2007.

Global Vaccine Alliance Board Approves $3.5B Investment Strategy That Includes HPV Vaccine
The board of the Global Alliance for Vaccines and Immunisation (GAVI) -- a public-private partnership that invests in childhood vaccinations in developing countries -- endorsed a $3.5 billion vaccine investment

Audit Finds Reported Cervical Cancer Cases In Maryland Deliberately Altered In State Database
The number of reported cervical cancer cases in Maryland was deliberately overreported in a state database that records the number of cancer cases statewide, according to a recent audit conducted by the Department of Legislative Services, the

VGX Pharmaceuticals Receives FDA Approval Of IND For Novel DNA Vaccine For Cervical Cancer Therapy
VGX Pharmaceuticals, Inc. (VGX) announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its DNA vaccine for cervical cancer therapy, VGX-3100. The Company expects to initiate the Phase I clinical study for VGX-3100 in patients in a multi-center study in the third quarter of 2008. More information on this study is available

Science Fiction Becomes Reality As Deadly Bacteria Battles Cancer
In the United States alone, approximately three-and-a-half million women have abnormal Pap smear tests each year. More than a third of these women develop cervical dysplasia, also known as Cervical Intraepithelial Neoplasia (CIN), a condition caused by the sexually transmitted Human Papilloma Virus (HPV). Stages I & II are considered a precancerous abnormality, but not an actual cancer; stage III is a pre-invasive form of cervical cancer.

University Of Iowa To Begin Using LUMA(R) Cervical Pre Cancer Imaging Device
SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego-based medical devices company, announced that it has placed its LUMA Cervical Imaging System to detect pre-cancers at the University of Iowa in Iowa City, Iowa under the direction of Dr. Colleen Kennedy. Dr.

Minister Harney Approves Introduction Of Cervical Cancer Vaccination Programme
The Minister for Health and Children, Mary Harney T.D., announced that she has asked the HSE to prepare and submit a plan for the introduction of a HPV vaccination programme for 12 year old girls to commence in September 2009.

Nventa Announces Final Data From HspE7 Phase 1 Cervical Dysplasia Trial
Nventa Biopharmaceuticals Corporation (TSX: NVN) announced that it has completed analysis of immunological data from all four cohorts of its Phase 1 clinical trial for HspE7, its lead product candidate. HspE7 is a therapeutic treatment for patients with cervical intraepithelial neoplasia, or CIN, a precursor to cervical cancer. The primary cause of CIN is infection with certain human papillomavirus (HPV) types, of which HPV16 is the most common.

Merck Responds To Questions About Adverse Events Reported Following Vaccination With GARDASIL�
Merck issued the following statement to address questions about adverse events reported in people who had received GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant]. Merck has analyzed the adverse events reported for GARDASIL relating to the recent reports of death and paralysis, and based on the data available to Merck, believes that no safety issue related to the vaccine has been identified.

Sex During Adolescence Doesn't Predict Future HPV Infection
Predicting a child's future is a near impossible task - today's straight-A student may not become tomorrow's doctor, and the school-yard bully may actually grow up to become a member of the Peace Corps. So why should an adolescent's sexual behavior- or lack thereof - determine whether or not she gets vaccinated against the human papillomavirus, to protect against future HPV infection? It shouldn't, say researchers at the University of Michigan C.S.

Fpa Statement On New Cervical Cancer Vaccine, UK
Reacting to today's announcement that the Department of Health is going to use the Cervarix HPV vaccine, that protects young women against cervical cancer in their nationwide vaccination programme, Julie Bentley, Chief Executive fpa said: "While we of course welcome the introduction

Merck Responds To Questions About Adverse Events Reported Following Vaccination With GARDASIL®
Merck issued the following statement to address questions about adverse events reported in people who had received GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant]. Merck has analyzed the adverse events reported for GARDASIL relating to the recent reports of death and paralysis, and based on the data available to Merck, believes that no safety issue related to the vaccine has been identified.

GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009
GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its human papillomavirus vaccine Cervarix until late 2009, Reuters reports. GSK said it has decided to wait until results from a Phase III trial of the vaccine are available before seeking U.S. approval.

Nventa Announces Final Data From HspE7 Phase 1 Cervical Dysplasia Trial
Nventa Biopharmaceuticals Corporation (TSX: NVN) announced that it has completed analysis of immunological data from all four cohorts of its Phase 1 clinical trial for HspE7, its lead product candidate. HspE7 is a therapeutic treatment for patients with cervical intraepithelial neoplasia, or CIN, a precursor to cervical cancer. The primary cause of CIN is infection with certain human papillomavirus (HPV) types, of which HPV16 is the most common.

BASHH Expresses Disappointment That The Government Missed The Chance To Eradicate Genital Warts From The Medical Map
The British Association for Sexual Health and HIV (BASHH) today expressed disappointment that the Government has missed the opportunity to eradicate a common STI, genital warts, from the medical map, as today's announcement by the Department of Health on the human papillomavirus vaccine (HPV), "Department of Health awards contract for HPV vaccine", saw GlaxoSmithKline's vaccine Ceravix awarded the Government contract.

Science Fiction Becomes Reality As Deadly Bacteria Battles Cancer
In the United States alone, approximately three-and-a-half million women have abnormal Pap smear tests each year. More than a third of these women develop cervical dysplasia, also known as Cervical Intraepithelial Neoplasia (CIN), a condition caused by the sexually transmitted Human Papilloma Virus (HPV). Stages I & II are considered a precancerous abnormality, but not an actual cancer; stage III is a pre-invasive form of cervical cancer.